NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Algen Biotechnologies

Algen Biotechnologies

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.algenbio.com/

Last Round

Seed

Aug 31, 2021

Total Funding Raised

$5.4M

Company Overview

Algen Biotechnologies is a biotechnology company that has developed a platform for therapeutics and drug discovery using CRISPR and AI to find treatments for cancer, inflammation and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Infrastructure

Keywords

AI drug discoverydrug discovery platformCRISPR platformtherapeutic target identificationtechbiogene modulationfull-stack drug discoverycausal biologyfunctional genomicsplatform therapeuticsgenerative biologyoncology drug discoveryinternal drug pipelinedisease modelingpharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Algen Biotechnologies Comparables

Compare Algen Biotechnologies with similar companies based on industry and business-model similarity.

Algen Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insitro
83%
Transcripta Bio
81%
Myllia Biotechnology
81%

Algen Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 31, 2021

Algen Biotechnologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2025

    Monthly visitors increased 1797% MoM, reaching 1.1K.

  • Aug 31, 2021

    $5.4M raised from Sequoia Capital and others.

Algen Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Algen Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Algen Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range18
Year Founded2018
Last FundingAug 31, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.